Fully diluted valuation of around $47m appears high at the moment considering the Medivisor business was acquired for $7,701,282 at the end of last year. Current MDR revenue being generated is low so plenty of growth being factored into the stock price.
Nothing really stopping another App offering the same service or chemists/GP'S being part of another provider's app but MDR having first mover advantage is a bonus. Chemist warehouse does around 20% of the prescription market so i wonder if they will have their own app.
As for GP Link imo it will take some time for doctors to get patients to not see them and instead order prescriptions online as visiting the GP every few months gives the GP time to discuss how your condition is going , any drug side effects and possibly get some more tests done or referrals. For certain health conditions and depending on the GP's attitude and medical centre's opinion it may allow some people to get repeat prescriptions.
Add to My Watchlist
What is My Watchlist?
